ResMed Inc. vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? ResMed Inc. trades at $197.45 (market cap $28.81B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.67. The key difference: ResMed Inc. pays a 1.21% dividend while YieldMax Magnificent 7 Fund of Option Income ETFs pays none. Which is the better fit depends on your goals.
| RMD | YMAG | |
|---|---|---|
Market Cap | $28.81B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $293.73 | $15.98 |
52-Week Low | $182.82 | $11.00 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | — |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →